Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between AGS Transact IPO and Emcure Pharma IPO.
AGS Transact IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| AGS Transact IPO | Emcure Pharma IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Hdfc Bank Limited ICICI Securities Limited Jm Financial Limited |
Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
| Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
|
| Anchor Investor | Anchor Investor |
|
| IPO Allotment URL | IPO Allotment URL |
The total issue size of AGS Transact IPO is up to ₹680.00 Cr whereas the issue size of the Emcure Pharma IPO is . The final issue price of AGS Transact IPO is ₹175.00 per share and of Emcure Pharma IPO is .
| AGS Transact IPO | Emcure Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹166.00 per share | |
| Issue Price (Upper) | ₹175.00 per share | |
| Issue Price (Final) | ₹175.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 85 shares | |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | up to ₹800.00 Cr | |
| OFS Issue Size | 1,36,78,839 shares | |
| OFS Issue Size (Amount) | up to ₹680.00 Cr | |
| Issue Size Total | ||
| Issue Size Total (Amount) | up to ₹680.00 Cr |
AGS Transact IPO opens on Jan 19, 2022, while Emcure Pharma IPO opens on . The closing date of AGS Transact IPO and Emcure Pharma IPO is Jan 21, 2022, and , respectively.
| AGS Transact IPO | Emcure Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 19, 2022 | |
| Issue Close | Jan 21, 2022 | |
| Basis Of Allotment (Tentative) | Jan 27, 2022 | |
| Initiation of Refunds (Tentative) | Jan 28, 2022 | |
| Credit of Share (Tentative) | Jan 31, 2022 | |
| Listing date (Tentative) | Jan 31, 2022 | |
| Anchor Lockin End date 1 | Feb 26, 2022 | |
| Anchor Lockin End date 2 | Apr 27, 2022 |
AGS Transact IPO P/E ratio is , as compared to Emcure Pharma IPO P/E ratio of .
| AGS Transact IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.23% | |||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.07% | |||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2106.87 Cr. | |||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||
In the AGS Transact IPO retail investors (RII) are offered 1,43,37,348 shares while in Emcure Pharma IPO retail investors are offered 1,43,37,348 shares. Qualified institutional buyers (QIB) are offered 81,92,770 shares in AGS Transact IPO and in Emcure Pharma IPO.
| AGS Transact IPO | Emcure Pharma IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 81,92,770 shares | |
| NII | 61,44,578 shares | |
| RII | 1,43,37,348 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 2,86,74,696 shares |
AGS Transact IPO subscribed 7.79x in total, whereas Emcure Pharma IPO subscribed .
| AGS Transact IPO | Emcure Pharma IPO | |
|---|---|---|
| QIB (times) | 2.68x | |
| NII (times) | 25.61x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.08x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.79x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
